Company News

Tsetis Pharmaceutical Group actively contributed to the proceedings of the 2nd Arab-Hellenic Health Conference, held in Athens on June 10–11, 2026, bringing together senior government officials, business leaders, healthcare executives and investors from Greece and 16 Arab countries.

The Tsetis Pharmaceutical Group, on the initiative of its President, Julia Tsetis, has made a donation of significant social and symbolic value to the National and Kapodistrian University of Athens (NKUA), dedicated to the memory of the late Professor Ioanna Andreadou of the Department of Pharmacy, School of Health Sciences, NKUA.

The companies of the Tsetis Pharmaceutical Group, UNI-PHARMA and InterMed, once again participated in Vitafoods Europe, held in Barcelona, presenting their extensive portfolio of targeted food supplements while highlighting their strategic focus on the modern challenge of longevity.

Sustainability as a core element of business strategy and investment in people was at the center of the remarks delivered by Julia Tsetis at the Delphi Economic Forum XI.

UNI-PHARMA introduces a significant advancement in the field of food supplements for men’s health, reaffirming its ongoing investment in research and innovation.

Following InterMed’s dynamic participation at AEEDC Dubai -one of the largest and most internationally recognized events for the dental community- where it actively contributed to the scientific program with a lecture on dental implants that attracted strong attendance and significant scientific interest, the Tsetis Pharmaceutical Group of Companies marked its presence at another leading international healthcare event in the Middle East, WHX Dubai (formerly Arab Health).

UNI-PHARMA has been granted a European Patent (EP4181693B1) for Hepatrat®, an innovative dietary supplement in a bilayer tablet formulation.

A scientific event presenting the research supported to date through grants and scholarships—with an emphasis on studies aimed at improving cardiovascular health—was organized by the KLEON TSETIS Foundation on Wednesday, November 26, 2025.

It was in 2021, a few months after the murder of Garifallia Psarrakou, a postgraduate student in the Department of Pharmacy at the National and Kapodistrian University of Athens (NKUA), when the President of the Tsetis Group, Julia Tsetis, announced the establishment of a scholarship to be awarded by the Non-Profit organization KLEON TSETIS in memory of Garifallia, to students of the Department of Pharmacy of NKUA for research projects in the field of Pharmacology.

Julia Tsetis, Chair of UNI-PHARMA and InterMed, emphasized the transformative potential of Artificial Intelligence (AI) in the life sciences and pharmaceutical sectors, stressing that meaningful innovation can only be achieved through a synergistic integration of AI with human judgment, ethical principles, and strategic direction.